Genelux Corporation (GNLX)
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
$84.61M
Mr. Thomas Zindrick J.D.
15.00
Westlake Village, CA
Jan 26, 2023
-2.58
$-0.95
1.35
6.01
-1,802.85%
-2.84
-0.03
2.00
59.59
6.01
-58.74%
-110.28%
Similar stocks (15)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Terns Pharmaceuticals, Inc.
TERN
Celcuity Inc.
CELC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
Ikena Oncology, Inc.
IKNA
Immuneering Corporation
IMRX
Dyadic International, Inc.
DYAI
Monopar Therapeutics Inc.
MNPR
Cingulate Inc.
CING
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.01507%
Schwab U.S. Small-Cap ETF
SCHA
0.0011886212%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
Day One Biopharmaceuticals, Inc.
DAWN
Cullinan Oncology, Inc.
CGEM
Terns Pharmaceuticals, Inc.
TERN
Celcuity Inc.
CELC
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Compass Therapeutics, Inc.
CMPX
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
Ikena Oncology, Inc.
IKNA
Immuneering Corporation
IMRX
Dyadic International, Inc.
DYAI
Monopar Therapeutics Inc.
MNPR
Cingulate Inc.
CING
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (12)
iShares Micro-Cap ETF
IWC
0.01507%
Schwab U.S. Small-Cap ETF
SCHA
0.0011886212%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%